Review Article
Clinical Efficacy and Meta-Analysis of Stem Cell Therapies for Patients with Brain Ischemia
Table 4
The correlations of Barthel and clinical variables across studies by subgroup and heterogeneity analysis.
| Subgroup | Mean difference (95% CI) | (%) |
| Patients’ characteristics | | | Acute stoke | 12.61 (2.39, 22.84) | 84 | Chronic stroke | 7.19 (4.18, 10.20) | 0 | Cell type | | | MSC | 8.37 (4.83, 11.91) | 63 | Non-MSC | — | — | Route of delivery | | | Intravenous injection | 7.58 (3.85, 11.30) | 30 | Non-IV | 12.56 (−3.16, 28.27) | 91 | Follow-up period | | | <6 months | 5.2 (4.06, 6.34) | — | 6 months | 9.52 (4.92, 14.13) | 58 |
|
|